Clinical trials recruiting in Antwerp, Belgium
45
Recruiting trials
15
Conditions
Phase breakdown
Phase 1 3Phase 2 8Phase 3 11Phase 4 3Not applicable 23
Conditions recruiting in Antwerp, Belgium
Recruiting trials in Antwerp, Belgium
- A Long-term Extension Study of PCI-32765 (Ibrutinib)
- A Multicentric European Study to Promote Clinical Trial Readiness for STXBP1-related Disorders
- A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
- A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease
- A Study With CIT-013 in RA Patients
- A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
- A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.
- A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Alleviant ALLAY-HF Study
- Alleviant ALLAY-HFrEF Study
- Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
- Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer
- BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- Comparison of Conventional and Cooled Radiofrequency of the Genicular Nerves in Patients With Chronic Knee Pain
- Conservative Endometrioma Surgery
- ContraBand™: Safety & Feasibility Study (RM-20-01)
- Effectiveness of Kinesio Taping in Patients With Chronic Breast and/or Truncal Oedema After Treatment for Breast Cancer.
- Effectiveness of an eHealth Self-management Support Program for Persistent Pain After Breast Cancer Treatment
- Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal Cancer
- Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)
- Global Research Initiative for Patients Screening on MASH
- LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer
- Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer
- Methylated Biomarkers of Smoking as a Selection Tool in Participants for Lung Cancer Screening
- Performance After Cardiac Ablation in Endurance Athletes for Atrial Fibrillation
- Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma
- Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy
- ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
- Reliability and Validity of Ultrasound for the Assessment of Soft Tissue Properties After Breast Cancer Treatment
- Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.
- Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
- Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
- Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
- The European NAFLD Registry
- The Stress-obesity Axis: a Metabolomics Approach Towards Personalized Nutrition in Adolescents
- Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
- What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
- Who Fares Best With Mindfulness Meditation
Common questions
How many clinical trials are recruiting in Antwerp, Belgium?
45 recruiting trials have at least one study site in Antwerp, Belgium.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.